Immunotherapy duo aims to shrink colon tumors before surgery
Disease control
Not yet recruiting
This study tests whether two immunotherapy drugs, cemiplimab and fianlimab, can safely shrink colon tumors before surgery in people with stage II-III colon cancer that hasn't spread. Participants get two IV doses, then surgery, and are followed for up to three years. The goal is …
Phase: PHASE2 • Sponsor: John Strickler, M.D. • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC